245 related articles for article (PubMed ID: 31373842)
1. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
2. miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
Xie Q; Chen C; Li H; Xu J; Wu L; Yu Y; Ren S; Li H; Hua X; Yan H; Rao D; Zhang H; Jin H; Huang H; Huang C
Mol Ther; 2019 May; 27(5):1028-1038. PubMed ID: 30935821
[TBL] [Abstract][Full Text] [Related]
3. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
[TBL] [Abstract][Full Text] [Related]
4. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
5. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
[TBL] [Abstract][Full Text] [Related]
6. Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
Zeng X; Xu Z; Gu J; Huang H; Gao G; Zhang X; Li J; Jin H; Jiang G; Sun H; Huang C
Mol Cancer Ther; 2016 Mar; 15(3):512-22. PubMed ID: 26832795
[TBL] [Abstract][Full Text] [Related]
7. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
8. hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes.
Chowdhari S; Saini N
J Cell Physiol; 2014 Nov; 229(11):1630-8. PubMed ID: 24610393
[TBL] [Abstract][Full Text] [Related]
9. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
[TBL] [Abstract][Full Text] [Related]
10. Decreased c-Myc mRNA Stability via the MicroRNA 141-3p/AUF1 Axis Is Crucial for p63α Inhibition of Cyclin D1 Gene Transcription and Bladder Cancer Cell Tumorigenicity.
Li X; Tian Z; Jin H; Xu J; Hua X; Yan H; Liufu H; Wang J; Li J; Zhu J; Huang H; Huang C
Mol Cell Biol; 2018 Nov; 38(21):. PubMed ID: 30104251
[TBL] [Abstract][Full Text] [Related]
11. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6.
Wang X; Wu J; Lin Y; Zhu Y; Xu X; Xu X; Liang Z; Li S; Hu Z; Zheng X; Xie L
J Exp Clin Cancer Res; 2014 Sep; 33(1):69. PubMed ID: 25178497
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic role of
Jin H; Ma J; Xu J; Li H; Chang Y; Zang N; Tian Z; Wang X; Zhao N; Liu L; Chen C; Xie Q; Lu Y; Fang Z; Huang X; Huang C; Huang H
Autophagy; 2021 Apr; 17(4):840-854. PubMed ID: 32116109
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
Shin SS; Park SS; Hwang B; Moon B; Kim WT; Kim WJ; Moon SK
Oncol Rep; 2016 Oct; 36(4):2313-20. PubMed ID: 27573859
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of the cyclin-dependent protein kinase 6 in whitefish (Coregonus lavaretus) and its potential interplay with miR-34a.
Łakomiak A; Brzuzan P; Jakimiuk E; Florczyk M; Woźny M
Gene; 2019 May; 699():115-124. PubMed ID: 30858134
[TBL] [Abstract][Full Text] [Related]
17. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract][Full Text] [Related]
18. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
Li Q; Wang S; Wu Z; Liu Y
Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
Sun F; Fu H; Liu Q; Tie Y; Zhu J; Xing R; Sun Z; Zheng X
FEBS Lett; 2008 Apr; 582(10):1564-8. PubMed ID: 18406353
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.
Jiang G; Huang C; Li J; Huang H; Wang J; Li Y; Xie F; Jin H; Zhu J; Huang C
Carcinogenesis; 2018 Mar; 39(3):482-492. PubMed ID: 29409027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
